Joint research on the isolation and purification of Muse cells
First written in FY2017. 1 of 4 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024ReframedAnnual report
「The contracts that ended during the consolidated fiscal year were as follows. Contract end date: 15 March 2024. A license agreement for the sale to universities, pharmaceutical companies and other research institutions of a novel specific IgG-class antibody against SSEA-3, developed through joint research with 株式会社生命科学インスティテュート. Under this license agreement for the manufacture and sale of research deliverables, the company has changed from the previous arrangement to holding 100% of the rights to the products and will continue to manufacture and sell them.」
Although the sales license agreement with LSII ended, the arrangement was changed so that the company holds 100% of the rights to the products concerned and continues to manufacture and sell them. - FY2018AdvancedAnnual report
「We successfully produced an antibody against SSEA-3, a marker of Muse cells, and began selling it as a research-use reagent.」
In its research related to Muse cells with LSII, the company successfully produced a novel IgG-class antibody against the SSEA-3 marker in addition to pursuing isolation and purification research, and began selling it as a research-use reagent. - FY2018-Q1RestatedAnnual report
「We are conducting joint research with 株式会社生命科学インスティテュート (formerly 株式会社Clio, hereinafter “LSII”) on a regenerative medicine business using Muse cells. We are researching the isolation and purification of Muse cells and related processes. We are also holding discussions with LSII regarding future developments.」
The company continues its joint research with LSII on regenerative medicine using Muse cells, as well as research into their isolation and purification. - FY2017First statedAnnual report
「We are conducting joint research with 株式会社生命科学インスティテュート (formerly 株式会社Clio, hereinafter “LSII”) on a regenerative medicine business using Muse cells. We are researching the isolation and purification of Muse cells and related processes.」
The company is conducting joint research with LSII on regenerative medicine using Muse cells and pursuing research into their isolation and purification.